LACTOSE (INDIA)
|
The Current P/E Ratio of LACTOSE (INDIA) is 22.83.
Share Price | ₹125.4 | Feb 20,2025 |
Market Cap | ₹157.9 Cr | |
Earnings-TTM | ₹6.9 Cr | TTM-Standalone Results |
Price/Earnings | 22.83x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LACTOSE (INDIA)
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹157.9 Cr] as on Feb 20,2025
(/) Earnings [ ₹6.9 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 22.83x ]
Thus, for LACTOSE (INDIA) , the investors are currently willing to pay 22.83 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LACTOSE (INDIA) !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LACTOSE (INDIA) over the last five years.
Historical PE (Price/Earnings) ratio chart of LACTOSE (INDIA)
PE Ratio Performance Analysis for LACTOSE (INDIA)
- LACTOSE (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 68.02x.
- LACTOSE (INDIA) 's operated at median p/e ratio of 30.79x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LACTOSE (INDIA) 's p/e ratio peaked in Mar2020 at 237.62x.
- LACTOSE (INDIA) 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does LACTOSE (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LACTOSE (INDIA) | 6.92 | 22.83 | 157.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 34.88 | 400,617.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 76.76 | 158,655.0 |
CIPLA LTD | 5,000.43 | 23.90 | 119,511.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.25 | 104,734.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.00 | 97,705.1 |
MANKIND PHARMA LTD | 2,050.73 | 47.21 | 96,821.9 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.73 | 90,581.2 |
LUPIN LTD | 2,892.10 | 31.21 | 90,273.7 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.60 | 65,099.1 |
ABBOTT INDIA LTD | 1,334.46 | 46.85 | 62,514.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LACTOSE (INDIA) 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.00x |
Max industry PE | 76.76x |
Median industry PE | 31.21x |
Average industry PE | 36.02x |
You may also like the below Video Courses